eMix has released Version 2.0 of its cloud-based medical-image exchange solution — including a new capability that enhances the immediate transmission of medical imaging files and related information.
The Healthcare Accreditation Colloquium announced that Texas Children's Hospital has earned the designation of Accredited Pediatric Heart Failure Institute following 12 months of work and an extensive onsite review.
Stentys has announced the publication of an article in the Journal of the American College of Cardiology (JACC) entitled, "Causes of Early Stent Thrombosis in Patients Presenting with Acute Coronary Syndrome: An Ex Vivo Human Autopsy Study."
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The Aplio 500 CV is the system of choice for all premium 2-D cardiac exams. Featuring Toshiba's 2-D Wall Motion Tracking ...
July 18, 2014 — Cook Medical customers in the United States will again have access to its Evolution RL and Evolution Shortie RL controlled-rotation dilator sheath sets. Distribution of these products within the U.S. market was suspended for two months while Cook’s Lead Management clinical division worked with the U.S. Food and Drug Administration (FDA) to resolve agency questions about the marketing clearance of these products.
July 18, 2014 — Avinger announced that John Pigott, M.D., of Jobst Vascular Institute, Toledo, Ohio, enrolled the first patient in the VISION trial, a global investigational device exemption (IDE) clinical trial approved by the U.S. Food and Drug Administration (FDA) to evaluate the Pantheris catheter for the treatment of peripheral artery disease (PAD).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 18, 2014 — AliveCor announced that more than one million ECGs (electrocardiograms) have been recorded using the AliveCor heart monitor since the first ECG was recorded in January 2013.
July 18, 2014 — The Freedom portable driver has received U.S. Food and Drug Administration (FDA) approval for use with the SynCardia temporary total artificial heart as a bridge to transplantation in cardiac transplant candidates who are clinically stable.
Boston Scientific Corp. received CE mark and began the European commercial launch of its new 25 mm Lotus transcatheter aortic valve implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Children's Hospital of Philadelphia (CHOP) launched the Fetal Neuroprotection and Neuroplasticity Program.
July 17 2014 — The Journal of the American Society of Echocardiography (JASE) announced the publication of a new consensus statement on the use of focused cardiac ultrasound (FoCUS) in its July 2014 issue.
A study by researchers at CVS Caremark, Aetna and Brigham and Women’s Hospital published in the May issue of Health Affairs, finds that eliminating copays for preventive medications prescribed for post-heart attack patients, can significantly improve medication adherence and health outcomes for non-white patients.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
CorMatrix Cardiovascular and the Central Clinical Hospital of the Ministry of Interior in Warsaw (Centralny Szpital Kliniczny MSW) of Warsaw, Poland, announced the successful enrollment and treatment of five patients in the first ever study evaluating the CorMatrix ECM delivered trans-epicardially for the improvement of myocardial function in patients at risk or suffering from congestive heart failure (CHF).
A new physician poster presentation at the Atrial Fibrillation Symposium 19th Annual International Meeting in Orlando, Fla., reports long-term outcomes for the convergent procedure, a multidisciplinary epicardial-endocardial approach to treat patients with persistent atrial fibrillation (AF)
Each year, deep vein thrombosis (DVT) leads to hospitalization for approximately 250,000 Americans, and often leads to serious — and even fatal —complications. Fortunately, at the California Institute for Deep Venous Thrombosis, those suffering from the effects of thrombosis will find an effective DVT treatment from Farshad Malekmehr.